Brief introduction of Tianyao joint-stock company

Tianjin Tianyao Pharmaceutical Co., Ltd. was reorganized by the original sponsor Tianjin Pharmaceutical Co., Ltd. (now renamed Tianjin Pharmaceutical Group Co., Ltd.) with its raw material drug production and operation assets as input. Tianjin New Technology Industrial Park Science and Technology Development Co., Ltd. (now renamed Tianjin New Technology Industrial Park Haitai Technology Investment Management Co., Ltd.), Tianjin Central Pharmaceutical Co., Ltd., Tianjin Darentang Pharmaceutical Factory (now merged by Sino-Singapore Pharmaceutical Co., Ltd.) and Tianjin Pharmaceutical Packaging and Printing Factory were established as inputs. The main business of Tianjin Pharmaceutical Co., Ltd., the main sponsor of the company, is mainly divided into two parts: raw material medicine products and preparation products. With the approval of Tianjin Municipal People's Government, when the company was established, all the production and operation assets of its API products were invested in the joint-stock company, with total assets of 404,336,365,438+05.03 yuan, liabilities of 265,536,5438+0,480.24 yuan and net assets of 6,544 yuan. The other four legal entities each contributed RMB 65,438+0,387,926 in cash, which was converted into 65,438+0,000,000 shares of legal entities according to the share conversion ratio of 72.05%. Tianjin State-owned Assets Administration Bureau agreed to the equity disposal plan of the joint-stock company, with the document number JZZ [1999]3 17. With the approval of Tianjin Economic System Reform Commission, Tianjin Municipal Government approved the establishment of joint-stock company in document1999165438 [1999] 9 on June 26th, and was approved by Tianjin Administration for Industry and Commerce, the registration authority, at199912/.